BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid Biopsy

Title
BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid Biopsy
Authors
Keywords
BRCA reversion, Circulating tumor DNA, ctDNA, Metastatic breast cancer, PARP inhibitor
Journal
Clinical Breast Cancer
Volume 18, Issue 2, Pages 184-188
Publisher
Elsevier BV
Online
2017-12-21
DOI
10.1016/j.clbc.2017.12.010

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More